---
title: "綠葉製藥自主研發的創新制劑 ERZOFRI®獲得 FDA 批准用於治療精神分裂症和分裂情感性障礙"
description: "綠葉製藥自主研發的創新制劑 ERZOFRI®獲得 FDA 批准，用於治療精神分裂症和分裂情感性障礙。這是首個由中國公司開發的棕櫚酸帕利哌酮長效注射劑，每月給藥一次。該產品有望為患者提供新的治療選擇。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/210019068.md"
published_at: "2024-07-28T11:05:02.000Z"
---

# 綠葉製藥自主研發的創新制劑 ERZOFRI®獲得 FDA 批准用於治療精神分裂症和分裂情感性障礙

> 綠葉製藥自主研發的創新制劑 ERZOFRI®獲得 FDA 批准，用於治療精神分裂症和分裂情感性障礙。這是首個由中國公司開發的棕櫚酸帕利哌酮長效注射劑，每月給藥一次。該產品有望為患者提供新的治療選擇。

智通財經 APP 訊，綠葉製藥 (02186) 公佈，該集團自主研發的創新制劑 ERZOFRI®(棕櫚酸帕利哌酮緩釋混懸注射液，亦稱為 LY03010) 已獲美國食品藥品監督管理局 (FDA) 上市批准，用於精神分裂症成人患者的治療、以及作為單藥或者作為心境穩定劑或抗抑鬱藥的輔助療法用於分裂情感性障礙成人患者的治療。

ERZOFRI®是首個在美國獲批具有自主知識產權且由中國公司開發的棕櫚酸帕利哌酮長效注射劑，每月給藥一次。該產品於 2023 年獲得美國發明專利授權 (美國專利編號：11,666,573)，專利將於 2039 年到期。ERZOFRI®在美國通過 505(b)(2) 的途徑獲得新藥上市批准。

據公開信息顯示：現有的棕櫚酸帕利哌酮長效注射劑 2023 年在美國市場的銷售額為 28.97 億美元。ERZOFRI®上市後有望為患者提供新的治療選擇。

### Related Stocks

- [02186.HK - 綠葉制藥](https://longbridge.com/zh-HK/quote/02186.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 08:31 ETChampion Angora Ranch in West Texas Hits Market for First Time in Nearly a Century | The Champion Angora Ranch in West Texas is on the market for the first time in nearly a century, listed at $9,760,000. S | [Link](https://longbridge.com/zh-HK/news/276338535.md) |
| After downtown Greensboro closures, DGI president says challenges remain, but ‘we do have energy’ | Downtown Greensboro has faced several restaurant closures recently, prompting concerns about the area's vitality. DGI Pr | [Link](https://longbridge.com/zh-HK/news/276471919.md) |
| I'm 72 and started claiming Social Security at 69. Will I get more money if I work part-time? | The Social Security Administration allows beneficiaries to work part-time after starting benefits, potentially increasin | [Link](https://longbridge.com/zh-HK/news/276239179.md) |
| 12:17 ETYoung Immigrants Advancing Biomedical Science Eligible for $50,000 Vilcek Prizes for Creative Promise | The Vilcek Foundation is accepting applications for the 2027 Vilcek Prizes for Creative Promise in Biomedical Science un | [Link](https://longbridge.com/zh-HK/news/276151122.md) |
| Tesla Releases New FSD Safety Stats After Crossing 8.2 Billion Miles Driven | Tesla has announced that its vehicles have surpassed 8.2 billion miles driven using Full Self-Driving (FSD) technology.  | [Link](https://longbridge.com/zh-HK/news/276390920.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。
